Epichem receives Intel capital
Epichem has announced that Intel Capital has completed an investment in the company. Intel Capital was the only investor in this funding round. The terms of the investment were not disclosed. Epichem has not previously raised funding through venture capital investors.
Precursors are the specific chemical starting materials from which the computer and communication chips are made. These highly tailored molecules influence the properties and the speed of the material systems and so are key to achieving the desired end result.
Barry Leese, Chief Executive of Epichem Group welcomed the investment and the recognition of the importance of new materials to provide enabling technology to this fast moving innovative sector. “Epichem’s extensive in-house technical expertise, as well as its strong links to key academic centres in the UK and USA, continues to be a great advantage”, said Leese. “This funding by Intel Capital will help to ensure that Epichem can solve some of the challenges presented by Moore’s Law to meet the manufacturing requirements for future-generation devices.”
“Over the past two decades, Moore's Law has driven the need for newer elements and materials in semiconductor manufacturing," said Keith Larson, Intel Capital Sector Director, Manufacturing and Digital Health. “Intel Capital is pleased to lead investments in companies, such as Epichem, to help accelerate development of novel materials, required by the semiconductor industry in the foreseeable future."